Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots

Journal of Clinical Microbiology

Volumn 45, Issue 10, 2007, Pages 3342-3351

  Steegen, Kim ^a,b,e   Luchters, Stanley ^a,b   Demecheleer, Els ^a   Dauwe, Kenny ^a   Mandaliya, Kishor ^c   Jaoko, Walter ^d   Plum, Jean ^a   Temmerman, Marleen ^a   Verhofstede, Chris ^a  

^a GHENT UNIVERSITY   (Belgium)

^b International Centre for Reproductive Health Kenya   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD; FEASIBILITY STUDY; FOUNDER EFFECT; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REPRODUCIBILITY; RNA SEQUENCE; VIRUS LOAD;

DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEASIBILITY STUDIES; HIV-1; HUMANS; MUTATION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35348926348     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00814-07     Document Type: Article

References (43)

1. Alvarez-Muñoz, M. T., S. Zaragoza-Rodrignez, O. Rojas-Montes, G. Palacios-Saucedo, G. Vazquez-Rosales, A. Gomez-Delgado, J. Torres, and O. Munoz. 2005. High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Arch. Med. Res. 36:382-386.
2. Arya, S. C. 1993. Stability of human immunodeficiency virus type 1 antibodies in whole blood-impregnated filter papers under various tropical conditions. J. Clin. Microbiol. 31:765-766.
3. Ayele, W., R. Schuurman, T. Messele, W. Dorigo-Zetsma, Y. Mengistu, J. Goudsmit, W. A. Paxton, M. P. de Baar, and G. Pollakis. 2007. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J. Clin. Microbiol. 45:891-896.
4. Beck, I. A., K. D. Drennan, A. J. Melvin, K. M. Mohan, A. M. Herz, J. Alarcon, J. Piscoya, C. Velazquez, and L. M. Frenkel. 2001. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J. Clin. Microbiol. 39:29-33.
5. Beebe, J. L., and L. C. Briggs. 1990. Evaluation of enzyme-linked immunoassay systems for detection of human immunodeficiency virus type 1 antibody from filter paper disks impregnated with whole blood. J. Clin. Microbiol. 28:808-810.
6. Bi, X., H. Gatanaga, S. Ida, K. Tsuchiya, S. Matsuoka-Aizawa, S. Kimura, and S. Oka. 2003. Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year. J. Acquir. Immune Defic. Syndr. 34:1-6.
7. Brambilla, D., C. Jennings, G. Aldrovandi, J. Bremer, A. M. Comeau, S. A. Cassol, R. Dickover, J. B. Jackson, J. Pitt, J. L. Sullivan, A. Butcher, L. Grosso, P. Reichelderfer, and S. A. Fiscus. 2003. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J. Clin. Microbiol. 41:1888-1893.
8. Bürgisser, P., P. Vernazza, M. Flepp, J. Boni, Z. Tomasik, U. Hummel, G. Pantaleo, J. Schupbach, et al. 2000. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. J. Acquir. Immune Defic. Syndr. 23:138-144.
9. Cassol, S., M. J. Gill, R. Pilon, M. Cormier, R. F. Voigt, B. Willoughby, and J. Forbes. 1997. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J. Clin. Microbiol. 35:2795-2801.
10. Chew, C. B., S. J. Potter, B. Wang, Y. M. Wang, C. O. Shaw, D. E. Dwyer, and N. K. Saksena. 2005. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J. Clin. Virol. 33:206-216.
11. Coffie, P., D. Ekouevi, M. L. Chaix, B. Tonwe-Gold, S. Toure, I. Viho, C. Amani-Bosse, V. Leroy, C. Rouzioux, F. Dabis, and MTCT-Plus Initiative of ICAP. 2007. Short-course zidovudine and lamivudine or single-dose nevirapine-containing PMTCT compromises 12-month response to HAART in African women, Abidjan, Côte d'Ivoire. 14th Conf. Retrovir. Opportunistic Infect., abstr. 93LB.
12. Crowe, S., S. Turnbull, R. Oelrichs, and A. Dunne. 2003. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin. Infect. Dis. 37:S25-S35.
13. Deeks, S. G., T. Wrin, T. Liegler, R. Hoh, M. Hayden, J. D. Barbour, N. S. Hellmann, C. J. Petropoulos, J. M. McCune, M. K. Hellerstein, and R. M. Grant. 2001. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N. Engl. J. Med. 344:472-480.
14. Devereux, H. L., C. Loveday, M. Youle, C. A. Sabin, A. Burke, and M. Johnson. 2000. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res. Hum. Retrovir. 16:1025-1030.
15. Fischer, A., C. Lejczak, C. Lambert, J. Servais, N. Makombe, J. Rusine, T. Staub, R. Hemmer, F. Schneider, J. C. Schmit, and V. Arendt. 2004. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J. Clin. Microbiol. 42:16-20.
16. Fiscus, S. A., D. Brambilla, L. Grosso, J. Schock, and M. Cronin. 1998. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J. Clin. Microbiol. 36:258-260.
17. Fiscus, S. A., B. Cheng, S. M. Crowe, L. Demeter, C. Jennings, V. Miller, R. Respess, and W. Stevens. 2006. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3:e417.
18. Fortes, P., J. Menitove, A. Ross, R. Steece, K. Cabrian, C. Ferrera, P. A. Perkins, J. Sturge, R. Lealos, and M. S. Krieger. 1989. Evaluation of blood collected on filter paper for detection of antibodies to human immunodeficiency virus type 1. J. Clin. Microbiol. 27:1380-1381.
19. IATA. 2007. IATA dangerous goods regulations, 48th ed. IATA, Montreal, Canada.
20. Johnson, V. A., F. Brun-Vezinet, B. Clotet, D. R. Kuritzkes, D. Pillay, J. M. Schapiro, and D. D. Richman. 2006. Update of the drug resistance mutations in HIV-1: fall 2006. Top. HIV Med. 14:125-130.
21. Koch, N., N. Yahi, F. Ariasi, J. Fantini, and C. Tamalet. 1999. Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy. J. Clin. Virol. 37: 1595-1597.
22. Li, C. C., K. D. Seidel, R. W. Coombs, and L. M. Frenkel. 2005. Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J. Clin. Microbiol. 43:3901-3905.
23. Lindhardt, B. O., I. C. Bygbjerg, K. Ulrich, H. D. Petersen, I. Lausen, and B. Frederiksen. 1987. Detection of antibodies to human immunodeficiency virus (HIV) in eluates from whole blood impregnated filter paper discs. J. Virol. Methods 18:73-77.
24. McNulty, A., C. Jennings, D. Bennett, J. Fitzgibbon, J. W. Bremer, M. Ussery, M. L. Kalish, W. Heneine, and J. G. Garcia-Lerma. 2007. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J. Clin. Microbiol. 45:517-521.
25. Mwaba, P., S. Cassol, A. Nunn, R. Pilon, C. Chintu, M. Janes, and A. Zumla. 2003. Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 362:2067-2068.
26. Mwaba, P., S. Cassol, R. Pilon, C. Chintu, M. Janes, A. Nunn, and A. Zumla. 2003. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 362:1459-1460.
27. Noë, A., J. Plum, and C. Verhofstede. 2005. The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance. J. Antimicrob. Chemother. 55:410-412.
28. Nyambi, P. N., K. Fransen, H. De Beenhouwer, E. N. Chomba, M. Temmerman, J. O. Ndinya-Achola, P. Piot, and G. van der Groen. 1994. Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J. Clin. Microbiol. 32:2858-2860.
29. O'Shea, S., J. Mullen, K. Corbett, I. Chrystie, M. L. Newell, and J. E. Banatvala. 1999. Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 13:630-631.
30. Panteleeff, D. D., G. John, R. Nduati, D. Mbori-Ngacha, B. Richardson, J. Kreiss, and J. Overbaugh. 1999. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J. Clin. Microbiol. 37:350-353.
31. Pappaioanou, M., M. Kashamuka, F. Behets, S. Mbala, K. Biyela, F. Davachi, J. R. George, T. A. Green, T. J. Dondero, W. L. Heyward, et al. 1993. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS 7:483-488.
32. Patton, J. C., G. G. Sherman, A. H. Coovadia, W. S. Stevens, and T. M. Meyers. 2006. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clin. Vaccine Immunol. 13:152-155.
33. Plantier, J. C., R. Dachraoui, V. Lemee, M. Gueudin, F. Borsa-Lebas, F. Caron, and F. Simon. 2005. HIV-1 resistance genotyping on dried serum spots. AIDS 19:391-397.
34. Sarmati, L., E. Nicastri, I. Uccella, G. D'Ettorre, S. G. Parisi, L. Palmisano, C. Galluzzo, E. Concia, V. Vullo, S. Vella, and M. Andreoni. 2003. Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J. Clin. Microbiol. 41:1760-1762.
35. Sherman, G. G., G. Stevens, S. A. Jones, P. Horsfield, and W. S. Stevens. 2005. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J. Acquir. Immune Defic. Syndr. 38:615-617.
36. Steegen, K., E. Demecheleer, N. De Cabooter, D. Nges, M. Temmerman, P. Ndumbe, K. Mandaliya, J. Plum, and C. Verhofstede. 2006. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. J. Virol. Methods 133:137-145.
37. Sungkanuparph, S., W. Manosuthi, S. Kiertiburanakul, B. Piyavong, and W. Chantratitra. 2007. Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine + lamivudine + nevirapine in a resource-limited setting. 14th Conf. Retrovir. Opportunistic Infect., abstr. 663.
38. Van Laethem, K., K. Van Vaerenbergh, J. C. Schmit, S. Sprecher, P. Hermans, V. De Vroey, R. Schuurman, T. Harrer, M. Witvrouw, E. Van Wijngaerden, L. Stuyver, M. Van Ranst, J. Desmyter, E. De Clercq, and A. M. Vandamme. 1999. Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations. J. Acquir. Immune Defic. Syndr. 22:107-118.
39. Venturi, G., L. Romano, T. Carli, P. Corsi, L. Pippi, P. E. Valensin, and M. Zazzi. 2002. Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. Antivir. Ther. 7:245-250.
40. Verhofstede, C., A. Noe, E. Demecheleer, N. De Cabooter, F. Van Wanzeele, B. Van Der Gucht, D. Vogelaers, and J. Plum. 2004. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 35:473-483.
41. WHO. December 2006, posting date. AIDS epidemic update. World Health Organization, Geneva, Switzerland. http://data.unaids.org/pub/EpiReport /2006/2006_EpiUpdate_en.pdf.
42. WHO. 2006. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV related disease in adults and children. World Health Organization, Geneva, Switzerland. http: //www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf.
43. Ziemniak, C., A. George-Agwu, W. J. Moss, S. C. Ray, and D. Persaud. 2006. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247.